Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer's Disease

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2014 Apr 9

PMID 24710686

Citations 18

Authors

Zhaofei Wu

Yushan Zhu

Xingshui Cao

Shufeng Sun

Baolu Zhao

Affiliations

Soon will be listed here.

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of Alzheimer's disease (AD). However, it is obscure how amyloid-beta (Aβ) can impair mitochondria in the early stage of AD pathology. Using PrP-hAPP/hPS1 double-transgenic AD mouse model, we find that abnormal mitochondrial morphology and damaged mitochondrial structure in hippocampal neurons appear in the early stage of AD-like disease development. We also find consistent mitochondrial abnormalities in the SH-SY5Y cells, which express amyloid precursor protein (APP) Swedish mutation (APPsw) and have been used as a cell model of the early-onset AD. Significant changes of mitofusin GTPases (Mfn1 and Mfn2) were detected both in the PrP-hAPP/hPS1 brains and SH-SY5Y cells. Moreover, our results show that Aβ accumulation in neurons of PrP-hAPP/hPS1 mice can affect the neurogenesis prior to plaque formation. These findings suggest that mitochondrial impairment is a very early event in AD pathogenesis and abnormal expression of Mfn1 and Mfn2 caused by excessive intracellular Aβ is the possible molecular mechanism. Interestingly, L-theanine has significant effects on regulating mitochondrial fusion proteins in SH-SY5Y (APPsw) cells. Overall, our results not only suggest a new early mechanism of AD pathogenesis but also propose a preventive candidate, L-theanine, for the treatment of AD.

Citing Articles

Mitochondrial dynamics proteins as emerging drug targets.

Zacharioudakis E, Gavathiotis E Trends Pharmacol Sci. 2022; 44(2):112-127.

PMID: 36496299 PMC: 9868082. DOI: 10.1016/j.tips.2022.11.004.

Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K/Akt/mTOR signaling pathway.

Wang R, Ha K, Dhandapani S, Kim Y J Nanobiotechnology. 2022; 20(1):441.

PMID: 36209164 PMC: 9548198. DOI: 10.1186/s12951-022-01576-6.

Age-Dependent Behavioral and Metabolic Assessment of Knock-in (KI) Mice.

Wang S, Ichinomiya T, Savchenko P, Devulapalli S, Wang D, Beltz G Front Mol Neurosci. 2022; 15:909989.

PMID: 35966019 PMC: 9373872. DOI: 10.3389/fnmol.2022.909989.

Reduced VDAC1, Maintained Mitochondrial Dynamics and Enhanced Mitochondrial Biogenesis in a Transgenic Tau Mouse Model of Alzheimer's Disease.

Vijayan M, Reddy P Int J Mol Sci. 2022; 23(15).

PMID: 35955694 PMC: 9368852. DOI: 10.3390/ijms23158561.

A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model.

Vijayan M, Alvir R, Alvir R, Bunquin L, Pradeepkiran J, Reddy P Aging Cell. 2022; 21(8):e13663.

PMID: 35801276 PMC: 9381918. DOI: 10.1111/acel.13663.

References

Considine M, Goodman M, Echtay K, Laloi M, Whelan J, Brand M . Superoxide stimulates a proton leak in potato mitochondria that is related to the activity of uncoupling protein. J Biol Chem. 2003; 278(25):22298-302. DOI: 10.1074/jbc.M301075200. View

Devi L, Prabhu B, Galati D, Avadhani N, Anandatheerthavarada H . Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci. 2006; 26(35):9057-68. PMC: 6675337. DOI: 10.1523/JNEUROSCI.1469-06.2006. View

Shen T, Zheng M, Cao C, Chen C, Tang J, Zhang W . Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis. J Biol Chem. 2007; 282(32):23354-61. DOI: 10.1074/jbc.M702657200. View

Hampel H, Shen Y, Walsh D, Aisen P, Shaw L, Zetterberg H . Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp Neurol. 2009; 223(2):334-46. PMC: 2896007. DOI: 10.1016/j.expneurol.2009.09.024. View

Cardoso S, Pereira C, Moreira P, Arduino D, Esteves A, Oliveira C . Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease. Exp Neurol. 2009; 223(2):294-8. DOI: 10.1016/j.expneurol.2009.06.008. View

Hirai K, Aliev G, Nunomura A, Fujioka H, Russell R, Atwood C . Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001; 21(9):3017-23. PMC: 6762571. View

Holcomb L, Gordon M, McGowan E, Yu X, Benkovic S, Jantzen P . Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998; 4(1):97-100. DOI: 10.1038/nm0198-097. View

Scheffler K, Krohn M, Dunkelmann T, Stenzel J, Miroux B, Ibrahim S . Mitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis. Acta Neuropathol. 2012; 124(2):199-208. PMC: 3694593. DOI: 10.1007/s00401-012-0980-x. View

Takahashi R, Almeida C, Kearney P, Yu F, Lin M, Milner T . Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci. 2004; 24(14):3592-9. PMC: 6729733. DOI: 10.1523/JNEUROSCI.5167-03.2004. View

10.

Kakuda T . Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res. 2011; 64(2):162-8. DOI: 10.1016/j.phrs.2011.03.010. View

11.

Sun X, He G, Qing H, Zhou W, Dobie F, Cai F . Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A. 2006; 103(49):18727-32. PMC: 1693730. DOI: 10.1073/pnas.0606298103. View

12.

Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z . β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med. 2010; 50(1):122-9. DOI: 10.1016/j.freeradbiomed.2010.10.707. View

13.

Kim T, Lee Y, Park S, Choi I, Ban J, Park H . l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med. 2009; 47(11):1601-10. DOI: 10.1016/j.freeradbiomed.2009.09.008. View

14.

Walsh D, Tseng B, Rydel R, Podlisny M, Selkoe D . The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry. 2000; 39(35):10831-9. DOI: 10.1021/bi001048s. View

15.

Fink B, Hong Y, Mathahs M, Scholz T, Dillon J, Sivitz W . UCP2-dependent proton leak in isolated mammalian mitochondria. J Biol Chem. 2001; 277(6):3918-25. DOI: 10.1074/jbc.M107955200. View

16.

Di X, Yan J, Zhao Y, Zhang J, Shi Z, Chang Y . L-theanine protects the APP (Swedish mutation) transgenic SH-SY5Y cell against glutamate-induced excitotoxicity via inhibition of the NMDA receptor pathway. Neuroscience. 2010; 168(3):778-86. DOI: 10.1016/j.neuroscience.2010.04.019. View

17.

Breyhan H, Wirths O, Duan K, Marcello A, Rettig J, Bayer T . APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy. Acta Neuropathol. 2009; 117(6):677-85. DOI: 10.1007/s00401-009-0539-7. View

18.

Aliev G, Palacios H, Walrafen B, Lipsitt A, Obrenovich M, Morales L . Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol. 2009; 41(10):1989-2004. DOI: 10.1016/j.biocel.2009.03.015. View

19.

Bao X, Li N, Wang T, Kong X, Tai W, Sun H . FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. PLoS One. 2013; 8(11):e78033. PMC: 3817172. DOI: 10.1371/journal.pone.0078033. View

20.

Aliyev A, Chen S, Seyidova D, Smith M, Perry G, de la Torre J . Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. J Neurol Sci. 2005; 229-230:285-92. DOI: 10.1016/j.jns.2004.11.040. View